Latest Articles

Publication Date
Group started for Moray folk affected by endometriosis - Forres Gazette

Group started for Moray folk affected by endometriosis Forres Gazette

Published: March 26, 2024, 7 a.m.
A comprehensive multiplatform metabolomic analysis reveals alterations of 2-hydroxybutyric acid among women with deep endometriosis related to the pesticide trans-nonachlor - ScienceDirect.com

A comprehensive multiplatform metabolomic analysis reveals alterations of 2-hydroxybutyric acid among women with deep endometriosis related to the pesticide trans-nonachlor ScienceDirect.com

Published: March 25, 2024, 7 a.m.
Doctors Say Diagnosis of Catherine’s Cancer Is a Familiar Scenario - The New York Times

Doctors Say Diagnosis of Catherine’s Cancer Is a Familiar Scenario The New York Times

Published: March 25, 2024, 7 a.m.
Study reveals breakthrough in non-invasive detection of endometrial cancer - News-Medical.Net

Study reveals breakthrough in non-invasive detection of endometrial cancer News-Medical.Net

Published: March 24, 2024, 7 a.m.
An endometrial receptivity scoring system evaluated by ultrasonography in patients undergoing frozen–thawed embryo transfer: a prospective cohort study - Frontiers

An endometrial receptivity scoring system evaluated by ultrasonography in patients undergoing frozen–thawed embryo transfer: a prospective cohort study Frontiers

Published: March 21, 2024, 7 a.m.
Serac highlights SPECT/CT study in women with endometriosis - AuntMinnie Europe

Serac highlights SPECT/CT study in women with endometriosis AuntMinnie Europe

Published: March 20, 2024, 7 a.m.
Immunotherapy Data “Very Much Practice-Changing” in Endometrial Cancer - Oncology News Central

Immunotherapy Data “Very Much Practice-Changing” in Endometrial Cancer Oncology News Central

Published: March 20, 2024, 7 a.m.
Endometriosis Awareness Month: Emilia Victoria from @LivingWithEndometriosis - HerCanberra

Endometriosis Awareness Month: Emilia Victoria from @LivingWithEndometriosis HerCanberra

Published: March 18, 2024, 7 a.m.
Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers - Cancer Therapy Advisor

Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers Cancer Therapy Advisor

Published: March 17, 2024, 7 a.m.
RUBY Part 2 trial results: Potentially practice changing results in advanced/recurrent endometrial cancer - EurekAlert

RUBY Part 2 trial results: Potentially practice changing results in advanced/recurrent endometrial cancer EurekAlert

Published: March 16, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!